Skip to content

Effect of CO2 fractional laser versus microneedling on treatment of patients with atrophic acne scars

Effect of CO2 fractional laser versus microneedling on treatment of patients with atrophic acne scars: a single blind randomized clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201701319014N142
Enrollment
23
Registered
2017-02-13
Start date
2017-02-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophic acne. Acne

Interventions

Intervention 1: Intervention group 1: Treatment of skin lesion with CO2 fractional laser 4 times with 3 weeks interval. Intervention 2: Intervention group 2: Treatment of skin lesion with microneedlin
Treatment - Drugs
Intervention group 1: Treatment of skin lesion with CO2 fractional laser 4 times with 3 weeks interval.
Intervention group 2: Treatment of skin lesion with microneedling 4 times with 3 weeks interval.

Sponsors

Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age of 18 to 65 years; atrophic acne. Exclusion criteria: Pregnancy or breastfeeding; Dermal disease or infection like impetigo; herpes simplex; flat wart; severe skin disease; susceptibility to keloid; acne rosacea; Active acne; using isotretinoin in the past 6 months; photosensitivity; psychological disorders.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Measuring skin lesions. Timepoint: before, and 1, 2, and 6 month after intervention. Method of measurement: with photography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Sina Khanali

Sina Hospital

sina.khanali@gmail.com+98 81 3827 4184

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026